When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Access free, up-to-date clinical references for comprehensive information on assessing multiple sclerosis at Healio. Our content provides valuable insights for physicians.

A new study by researchers in the Department of Clinical Neuroscience, Karolinska Institutet, has identified 18 potential ...

Panelists discuss how progression independent of relapse activity (PIRA) represents a distinct pathological process involving ...

Multiple sclerosis (MS) is a common immune-mediated progressive neurodegenerative disease of the CNS that typically manifests with periods of disease activity followed by intervals of remission ...

Anti-CD20 therapies, a type of MS treatment, changes levels and profiles of several immune cells in people with MS, a study ...

Illinois engineers fused ultrafast imaging with smart algorithms to peek at living brain chemistry, turning routine MRIs into ...

A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...

“To test MindGlide’s generalizability across ages 14–64, we employed an external validation set of two progressive MS clinical trials, and a real-world cohort of pediatric relapsing ...

The quest to mitigate disability progression in multiple sclerosis (MS) has long been hindered by our limited understanding ...

Immunic’s lead oral small molecule has failed to hit the primary endpoint of a phase 2 trial in patients with progressive multiple sclerosis (PMS), but the New York biotech is pointing to other ...

Access free, up-to-date clinical guidance on Multiple Sclerosis at Healio. We offer valuable insights for identifying, assessing, treating, and managing this condition.